245 related articles for article (PubMed ID: 848799)
1. Hemodynamic improvement after oral hydralazine in left ventricular failure: a comparison with nitroprusside infusion in 16 patients.
Franciosa JA; Pierpont G; Cohn JN
Ann Intern Med; 1977 Apr; 86(4):388-93. PubMed ID: 848799
[TBL] [Abstract][Full Text] [Related]
2. Combined oral hydralazine-nitrate therapy in left ventricular failure. Hemodynamic equivalency to sodium nitroprusside.
Pierpont GL; Cohn JN; Franciosa JA
Chest; 1978 Jan; 73(1):8-13. PubMed ID: 620563
[No Abstract] [Full Text] [Related]
3. Renal effects of nitroprusside and hydralazine in patients with congestive heart failure.
Cogan JJ; Humphreys MH; Carlson CJ; Rapaport E
Circulation; 1980 Feb; 61(2):316-23. PubMed ID: 7351056
[TBL] [Abstract][Full Text] [Related]
4. Quantitative differences in the hemodynamic effects of captopril and nitroprusside in severe chronic heart failure.
Packer M; Meller J; Medina N; Yushak M
Am J Cardiol; 1983 Jan; 51(1):183-8. PubMed ID: 6336876
[TBL] [Abstract][Full Text] [Related]
5. Hemodynamic effects of oral ephedrine given alone or combined with nitroprusside infusion in patients with severe left ventricular failure.
Franciosa JA; Cohn JN
Am J Cardiol; 1979 Jan; 43(1):79-85. PubMed ID: 758774
[No Abstract] [Full Text] [Related]
6. Hemodynamic comparison of primary venous or arteriolar dilatation and the subsequent effect of furosemide in left ventricular failure after acute myocardial infarction.
Nelson GI; Silke B; Forsyth DR; Verma SP; Hussain M; Taylor SH
Am J Cardiol; 1983 Nov; 52(8):1036-40. PubMed ID: 6637819
[TBL] [Abstract][Full Text] [Related]
7. Clinical use of sodium nitroprusside in chronic ischemic heart disease. Effects on peripheral vascular resistance and venous tone and on ventricular volume, pump and mechanical performance.
Miller RR; Vismara LA; Zelis R; Amsterdam EA; Mason DT
Circulation; 1975 Feb; 51(2):328-36. PubMed ID: 1112013
[TBL] [Abstract][Full Text] [Related]
8. Hemodynamic effects of nitroprusside and furosemide in left ventricular failure.
Franciosa JA; Silverstein SR
Clin Pharmacol Ther; 1982 Jul; 32(1):62-9. PubMed ID: 7083731
[TBL] [Abstract][Full Text] [Related]
9. Hemodynamic advantage of combined administration of hydralazine orally and nitrates nonparenterally in the vasodilator therapy of chronic heart failure.
Massie B; Chatterjee K; Werner J; Greenberg B; Hart R; Parmley WW
Am J Cardiol; 1977 Nov; 40(5):794-801. PubMed ID: 411364
[TBL] [Abstract][Full Text] [Related]
10. Oral hydralazine in chronic heart failure: sustained beneficial hemodynamic effects.
Chatterjee K; Ports TA; Brundage BH; Massie B; Holly AN; Parmley WW
Ann Intern Med; 1980 May; 92(5):600-4. PubMed ID: 7386999
[TBL] [Abstract][Full Text] [Related]
11. Comparative hemodynamic effects of inotropic and vasodilator drugs in severe heart failure.
Mikulic E; Cohn JN; Franciosa JA
Circulation; 1977 Oct; 56(4 Pt 1):528-33. PubMed ID: 902377
[TBL] [Abstract][Full Text] [Related]
12. Hemodynamic responses to combined therapy with captopril and hydralazine in patients with severe heart failure.
Massie BM; Packer M; Hanlon JT; Combs DT
J Am Coll Cardiol; 1983 Aug; 2(2):338-44. PubMed ID: 6345633
[TBL] [Abstract][Full Text] [Related]
13. "Optimal" left ventricular filling pressure during nitroprusside infusion for congestive heart failure.
Franciosa JA; Dunkman WB; Wilen M; Silverstein SR
Am J Med; 1983 Mar; 74(3):457-64. PubMed ID: 6829591
[No Abstract] [Full Text] [Related]
14. Differential hemodynamic and sympathoadrenal effects of sodium nitroprusside and hydralazine in hypertensive subjects.
Shepherd AM; Irvine NA
J Cardiovasc Pharmacol; 1986; 8(3):527-33. PubMed ID: 2425168
[TBL] [Abstract][Full Text] [Related]
15. [Haemodynamic response to sodium nitroprusside in healthy people and in patients with left heart failure (author's transl)].
Franke N; Peter K; Plaue R; van Ackern K
Prakt Anaesth; 1978 Dec; 13(6):513-9. PubMed ID: 740633
[TBL] [Abstract][Full Text] [Related]
16. Afterload reduction and cardiac performance. Physiologic basis of systemic vasodilators as a new approach in treatment of congestive heart failure.
Mason DT
Am J Med; 1978 Jul; 65(1):106-25. PubMed ID: 99030
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological mechanisms for left ventricular unloading in clinical congestive heart failure. Differential effects of nitroprusside, phentolamine, and nitroglycerin on cardiac function and peripheral circulation.
Miller RR; Vismara LA; Williams DO; Amsterdam EA; Mason DT
Circ Res; 1976 Jul; 39(1):127-33. PubMed ID: 819179
[TBL] [Abstract][Full Text] [Related]
18. Prevention of tolerance to hemodynamic effects of nitrates with concomitant use of hydralazine in patients with chronic heart failure.
Gogia H; Mehra A; Parikh S; Raman M; Ajit-Uppal J; Johnson JV; Elkayam U
J Am Coll Cardiol; 1995 Dec; 26(7):1575-80. PubMed ID: 7594088
[TBL] [Abstract][Full Text] [Related]
19. Comparison of hemodynamic responses to nifedipine and nitroprusside in severe chronic congestive heart failure.
Elkayam U; Weber L; Torkan B; McKay CR; Rahimtoola SH
Am J Cardiol; 1984 May; 53(9):1321-5. PubMed ID: 6711434
[TBL] [Abstract][Full Text] [Related]
20. Effects of oral hydralazine on rest and exercise hemodynamics in patients with aortic or mitral regurgitation and left ventricular dysfunction.
Slosky DA; Hindman MC; Peter RH; Wallace AG
Clin Cardiol; 1981; 4(4):162-7. PubMed ID: 7273499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
